Regulatory & Legal

A key regulatory win in Japan propels a potential first-ever treatment for Netherton Syndrome, but the real story is the high-wire act of global commercialization.

A crucial CAP accreditation for its advanced CNS cancer test positions Plus Therapeutics to unlock new markets and redefine patient care with precision diagnostics.

A new study reveals a vast spending gap across the GTHA. Is Toronto's high tab a sign of value or inefficiency? A look at the systems behind the numbers.

A landmark partnership in India offers a powerful blueprint for how industry and academia can co-create talent and bridge the critical AI skills gap.

Canaccord Genuity posts record profits and hikes its dividend, but behind the stellar numbers lies a crucial strategic review of its valuable UK business.

Over 5,200 mail carriers were attacked by dogs last year. Beyond the mailbag, this is a story of trauma, hidden financial liability, and a high-tech push for safety.

A rally against wind farms highlights a clash over golden eagles, but it reveals a deeper struggle over Wyoming's economic soul and the rules of energy transition.

A new report from 10a Labs on the AI social network Moltbook finds nearly one-fifth of agent interactions are malicious, exposing a new frontier of digital risk.

A proposed road for a remote First Nation is at a critical juncture, forcing a public debate on community needs, ecological risks, and a mining frontier.

A new roadside memorial for a mother and daughter killed in 2024 is more than a tribute; it's a stark reminder of a community's grief and a province's ongoing battle.

A new survey reveals a seismic shift in foundation governance. Boards are embracing term limits, rigorous self-assessments, and even compensation.

After production delays and quality recalls plagued its Brawley EV, Vanderhall is betting on a high-touch support program to win back its earliest adopters.

MIT's Kristin Forbes argues rigid models are failing. She's adapting Sun Tzu's 'Art of War' to help central banks fight today's lightning-fast crises.

The market for T-cell malignancy treatments is set to surpass $1.8B, fueled by a pipeline of innovative drugs aiming to meet vast unmet patient needs.

A near-record number of homeowners are delisting their properties in a silent retreat, signaling a major power shift from sellers to buyers.

Zepto Life Technology's FDA Breakthrough status for a fungal test isn't just a win for patients; it's a strategic move in liquid biopsy's new frontier.

The struggling biopharma secures cash, but its creative financing deal could dilute existing shareholder value by over 30%. A deep dive into the high-stakes world of biotech funding.

A new partnership between 700Credit and Quotible promises to streamline auto sales by putting financing first, offering a glimpse into a future of faster, more transparent deals.

A new $515M contract for the SPY-6 radar is more than a sale; it's a strategic play cementing U.S. tech dominance and revitalizing domestic manufacturing.

Insulet's latest Omnipod 5 enhancements are more than a software update; they're a strategic move in the diabetes tech race. Here's what it means.